Immutep Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immutep Ltd with three other
companies in this sector in AUSTRALIA :
Idt Australia Limited.
sales of 14.17 million Australian Dollars [US$10.80 million]
(12.55 million Australian Dollars [US$9.57 million]
of which 56%
was Mannitol), and
(7.48 million Australian Dollars [US$5.70 million]
of which 79%
was Advangen Japan).
During the year ended June of 2020, sales at
Immutep Ltd were A$13.94 million (US$10.62 million).
increase of 131.0%
versus 2019, when the company's sales were A$6.03 million.
Sales of Cancer Immunotherapy saw an increase
143.7% in 2020, from
A$5.64 million to A$13.74 million.